Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis

NACompletedINTERVENTIONAL

Enrollment

208

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

September 14, 2021

Study Completion Date

September 14, 2021

Conditions

Systemic Lupus ErythematosusSystemic Scleroderma

Interventions

BIOLOGICAL

blood sample

36 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation

BIOLOGICAL

urine sample

6 ml

Trial Locations (1)

CHU de Bordeaux - service de rhumatologie, Bordeaux

All Listed Sponsors

lead

University Hospital, Bordeaux

OTHER

NCT03575156 - Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis | Biotech Hunter | Biotech Hunter